Cryotherapy for Human Papillomavirus Clearance in Biopsy-confirmed Cervical Low-grade Squamous Intraepithelial Lesions (Cryotherapy)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00566579|
Recruitment Status : Terminated (Lack of additional funding)
First Posted : December 3, 2007
Results First Posted : August 2, 2010
Last Update Posted : August 10, 2010
|Condition or disease||Intervention/treatment||Phase|
|Human Papillomavirus Clearance at 12 Months||Procedure: Cryotherapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Cryotherapy for Human Papillomavirus Clearance in Biopsy-confirmed Cervical Low-grade Squamous Intraepithelial Lesions: a Randomized Controlled Trial|
|Study Start Date :||December 2007|
|Actual Primary Completion Date :||March 2009|
|Actual Study Completion Date :||March 2009|
Double-freezing cryotherapy was done within one month after the primary hpv testing was positive. Pap smear and colposcopy were done at 6 months and 12 months. HPV testing was repeated again at 12 months.
Double freezing technique
Other Name: Cryosurgery
No Intervention: B
Pap smear and colposcopy were done at 6 months and 12 months. HPV testing was repeated again at 12 months.
- Number of Patients With Human Papillomavirus Clearance [ Time Frame: 12 months ]At 12 months after treatment, a patient with negative results for HPV testing of previous types was considered as a clearance.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00566579
|Srinagarind Hospital, Faculty of Medicine, Khon Kaen University|
|Muang, Khon Kaen, Thailand, 40002|
|Principal Investigator:||Bandit Chumworathayi, MD||Gynecologic Oncology Division, OBGYN Department, Faculty of Medicine, Khon Kaen University|